Associated conditions and medications (Secondary Intracranial Hypertension).
| Associated conditions | n (%) |
|---|---|
| Vitamin D deficiency | 12 (22.6) |
| Craniosynostosis | 4 (7.5) |
| Down syndrome | 4 (7.5) |
| ADHD | 2 (3.8) |
| Spina bifida | 2 (3.8) |
| Achondroplasia | 1 (1.9) |
| Acute lymphoblastic leukaemia | 1 (1.9) |
| Atrioseptal Defect | 1 (1.9) |
| Autoimmune thyroiditis | 1 (1.9) |
| Bronchial asthma | 1 (1.9) |
| Cataract | 1 (1.9) |
| Mucopolysaccharidosis type VI | 1 (1.9) |
| Middle East Syndrome | 1 (1.9) |
| Minimal change disease | 1 (1.9) |
| MLC 1 gene mutation | 1 (1.9) |
| Obstructive sleep apnoea | 1 (1.9) |
| Epilepsy during infancy | 1 (1.9) |
| Retinitis pigmentosa | 1 (1.9) |
| Skeletal dysplasia | 1 (1.9) |
| Subaortic stenosis | 1 (1.9) |
| Sagittal “Dural” sinus thrombosis | 1 (1.9) |
| Medications | |
| Carbamazepine | 2 (3.77) |
| Growth hormone | 1 (1.9) |
| Steroid | 1 (1.9) |
| Cyclosporin | 1 (1.9) |
| Methotrexate | 1 (1.9) |
| ADHD - Attention deficit hyperactivity disorder | |